Literature DB >> 47831

The effects of fast neutrons on inoperable carcinoma of the stomach.

M Catterall, D Kingsley, G Lawrence, J Grainger, J Spencer.   

Abstract

Thirty-nine unselected patients suffering from inoperable, recurrent, or residual adenocarcinoma of the stomach were referred for palliation with fast neutrons from the Medical Research Council's cyclotron at Hammersmith Hospital. A full course of 1440 rads given in 12 treatments over 26 days was administered to the patients. Because of the relatively low energy (7-5 MeV) of the beam from this particular machine, it was not possible to deliver the full dose uniformly throughout the tumour except in extremely thin patients. Pain, dysphagia, vomiting, and bleeding were relieved in the majority of cases. The side effects were minimal and easily controlled. Palpable masses disappeared. Five patients required surgery after neutron therapy. All the incisions were made through irradioated tissue and all except one healed normally. Tumour was present outside the treated area, but the absence of any palpable mass within the treated area was a consistent finding. Radiologically, the stomachs remained abnormal and later changes included gross mucosal abnormality and shrinkage. Fourteen patients came to necropsy and in 10 no tumour was present macroscopocally. Tumour cells were seen in all except two cases but these were few, surrounded by dense fibrous tissue, and may not have been viable. The remaining stomach was abnormal with a thickened wall and destruction of mucosa. Three of the four cases in which macroscopic tumour was present received less than the standard dose because of the inadequate penetration of the beam. Excellent regression of tumors was achieved by the neutrons, but the stomachs did not recover from this satisfactorily. Gastrectomy four to six months after treatment is therefore suggested. This operation and other surgical procedures in other patients were successfully carried out. There is a need for higher energy neutrons to improve treatment and extend it to patients of thick-set build.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 47831      PMCID: PMC1410995          DOI: 10.1136/gut.16.2.150

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  7 in total

1.  Effects of million volt irradiation on the gastrointestinal tract.

Authors:  I B BRICK
Journal:  AMA Arch Intern Med       Date:  1955-07

2.  Effect of 2 million volt roentgen therapy on various malignant lesions of the upper abdomen.

Authors:  R J GUTTMANN
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1955-08

3.  The value of megavolt therapy in carcinoma of the stomach.

Authors:  E Nordman; C Kauppinen
Journal:  Strahlentherapie       Date:  1972-12

4.  Cancer of the stomach and oesophagus. Data concerning management and results.

Authors:  J I Burn
Journal:  Br J Surg       Date:  1971-10       Impact factor: 6.939

5.  The treatment of advanced cancer by fast neutrons from the Medical Research Council's cyclotron at Hammersmith Hospital, London.

Authors:  M Catterall
Journal:  Eur J Cancer       Date:  1974-06       Impact factor: 9.162

6.  Comparison between neutron therapy and 60Co gamma ray therapy of bronchial, gastric and oesophagus carcinomata.

Authors:  H J Eichhorn; A Lessel; S Matschke
Journal:  Eur J Cancer       Date:  1974-06       Impact factor: 9.162

7.  [Mega-volt therapy of malignant stomach neoplasms].

Authors:  C Wieland; U Hymmen
Journal:  Strahlentherapie       Date:  1970-07
  7 in total
  4 in total

Review 1.  Surgical progress 1975.

Authors:  H Ellis
Journal:  Postgrad Med J       Date:  1976-03       Impact factor: 2.401

2.  Adenocarcinoma of the stomach: radiological and pathological correlation of effects of treatment with fast neutrons.

Authors:  D Kingsley; A Gad; M Catterall
Journal:  Gut       Date:  1976-08       Impact factor: 23.059

3.  Carcinoma of the stomach. Why are we falling to improve survival?

Authors:  T E Weed; W Nuessle; A Ochsner
Journal:  Ann Surg       Date:  1981-04       Impact factor: 12.969

4.  An interim report of a prospective, randomized, controlled study of adjuvant chemotherapy in operable gastric cancer: British Stomach Cancer Group.

Authors:  J W Fielding; S L Fagg; B G Jones; D Ellis; M S Hockey; A Minawa; V S Brookes; J L Craven; M C Mason; A Timothy; J A Waterhouse; P F Wrigley
Journal:  World J Surg       Date:  1983-05       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.